By digging deeper into the cause of ALS, and studying the varying sub-forms of the disease, we are developing precision medications that can effectively treat ALS. The three sub-forms of ALS we are currently developing precision medicine for are:
Our mission at QurAlis is to develop treatments for ALS using precision medicine. ALS can affect anyone. It is a destructive disease which causes muscle paralysis through degeneration of the motor system. An ALS diagnosis is a death sentence to patients, with a predicted life expectancy of about 3 years following diagnosis.
MESSAGES OF HOPE
We can defeat ALS. We have brought world class ALS researchers, doctors and industry experts together to make the right therapies for the right ALS patients and we will not stop until we have succeeded in our mission.
Chief Executive Officer
I was introduced only relatively recently to the challenge of ALS and its devastating course in patients. The need for effective treatment is so great that I have become quite obsessed with contributing, both by exploring ALS disease mechanisms in my academic lab and as cofounder of QurAlis, and will not rest until we have made a meaningful impact in halting or preventing the disease.
Clifford J. Woolf
For the first time in history we have genuine reason to believe we can treat patients with some forms of ALS in the years to come.
Jonathan J. Fleming
We have known so little in the past about why motor neurons degenerate in ALS that it has been difficult to generate candidate therapeutics with the precision required for them to become actual cures. The transformative genetic and stem cell technologies being employed at QurAlis will allow us to test candidate therapeutics on motor neurons derived from patients during their development, greatly increasing our likelihood of eventual successful in later clinical trials.